DENVER - TriSalus Life Sciences Inc. (Nasdaq: TLSI), a $163 million market cap company focusing on improving outcomes for patients with solid tumors, has announced the addition of healthcare veterans ...

Donald Trump has agreed to suspend his aggressive tariff hike against Mexico by one month after speaking to his counterpart ...

Statins help people manage high cholesterol levels, but many experts want to know if these drugs can also support brain ...

New heart health biopharmaceutical company Kardigan, which counts among its co-founders the director for Northwestern ...

Aardvark Therapeutics plans a $100M IPO for metabolic treatments, targeting rare Prader-Willi syndrome with a potential ...

APAC offers stability in an increasing challenging global geopolitical environment for clinical stage drug development.

In this video, Xiuning Le, MD, PhD, discusses the state of the pipeline for developing EGFR-mutated lung cancer treatments.

IRA has unintended consequences on investment landscape for small- and large-molecule drugs stifling the development of new ...

Day One Biopharma's OJEMDA FDA approval for pediatric glioma, but market concerns remain. Check out why I rate DAWN stock as ...

Wong, Founder and CEO of HCW Biologics, commented, “The FDA’s clearance to initiate our first-in-human clinical trial for HCW9302 brings us one step closer to advancing a potentially transformative ...

The highly anticipated 3rd edition of Pharma Live Expo & Summit 2025, a premier event for the global pharmaceutical, healthcare, and MedTech sectors, will be held from 17th to 19th April 2025 at the ...